Evolent Health, Inc. (EVH) stock
EVHNYSEServices-Management ServicesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3055% below fair value
$4.62−0.21 (-4.35%)
Close on Nov 17, 2026Market cap $522.33MP/E –Yield –
Evolent Health gross margin
Gross margin is gross profit as a percentage of revenue.
Evolent Health's gross margin for the twelve months ending Jun 30, 2026 was 17.2%. For fiscal 2025 it was 21.3%, against 14.4% the year before. The highest annual figure on record is 27.6% in fiscal 2021.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 21.3% | +6.9 |
| FY2024 | Dec 31, 2024 | 14.4% | −9.1 |
| FY2023 | Dec 31, 2023 | 23.4% | +0.0 |
| FY2022 | Dec 31, 2022 | 23.4% | −4.2 |
| FY2021 | Dec 31, 2021 | 27.6% | +2.9 |
| FY2020 | Dec 31, 2020 | 24.7% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 12.4% | −10.2 |
| Q1 FY2026 | Mar 31, 2026 | 16.9% | −4.3 |
| Q4 FY2025 | Dec 31, 2025 | 20.7% | +9.0 |
| Q3 FY2025 | Sep 30, 2025 | 20.8% | +7.8 |
| Q2 FY2025 | Jun 30, 2025 | 22.6% | +6.1 |
| Q1 FY2025 | Mar 31, 2025 | 21.2% | +4.9 |
| Q4 FY2024 | Dec 31, 2024 | 11.7% | −6.6 |
| Q3 FY2024 | Sep 30, 2024 | 13.0% | −11.4 |
| Q2 FY2024 | Jun 30, 2024 | 16.5% | −8.5 |
| Q1 FY2024 | Mar 31, 2024 | 16.3% | −11.1 |
| Q4 FY2023 | Dec 31, 2023 | 18.3% | −3.4 |
| Q3 FY2023 | Sep 30, 2023 | 24.3% | −0.0 |
| Q2 FY2023 | Jun 30, 2023 | 25.0% | +3.0 |
| Q1 FY2023 | Mar 31, 2023 | 27.4% | +1.4 |
| Q4 FY2022 | Dec 31, 2022 | 21.7% | −12.1 |
| Q3 FY2022 | Sep 30, 2022 | 24.4% | −2.3 |
| Q2 FY2022 | Jun 30, 2022 | 22.0% | −0.5 |
| Q1 FY2022 | Mar 31, 2022 | 26.0% | – |
| Q4 FY2021 | Dec 31, 2021 | 33.8% | – |
| Q3 FY2021 | Sep 30, 2021 | 26.7% | – |
| Q2 FY2021 | Jun 30, 2021 | 22.5% | – |
See a number that looks wrong?